Oxford Nanopore Technologies today announces that the GridION™ Dx is now both CE and UKCA marked, making it the company’s first IVD device registered in the UK and Europe. The CE and UKCA ...

It has also become a big driver in the number of older single mothers in the U.S. at a time when the country's overall birth ...

Oxford Nanopore has reached a major regulatory milestone with the registration of its first In Vitro Diagnostic ("IVD") device in the UK and Europe: the GridION Dx. Oxford Nanopore Technologies today ...

MeMed Severity (TM) has received FDA Breakthrough Device Designation as a host-response test designed to predict severe outcomes up to 72 hours and mortality 14 days in advance in patients with acute ...

The Swiss healthtech startup’s patented multi-tissue platform is designed to improve the speed, safety, and human relevance ...

Over his nearly 50-year career, Burbank-based attorney Dennis Block has built a reputation as a staunch advocate for Southern ...

The longest living vertebrate on Earth may have a thing or two to teach us about maintaining our eyesight into old age. New ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

The physical and digital biobank supports the integration of artificial intelligence in acute care diagnostics development.

New options for testing and treating some of the most common sexually transmitted diseases are becoming available ...

Sinai Health researchers have shown a blood test that can predict Crohn's disease years before symptoms appear, opening the ...